CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Oppenheimer Adjusts Protara Therapeutics PT to $28 From $25, Maintains Outperform Rating

Positive
AI Analysis

Summary

Oppenheimer raised its price target for Protara Therapeutics from $25 to $28 while maintaining an Outperform rating.

Importance:2/10
Sentiment:
0.30
price_targetanalyst_ratingvaluation
Related Companies

Read the original article

Published by yahoo_finance on May 20, 2026 12:26 PM

Read Original